<DOC>
	<DOCNO>NCT00769158</DOCNO>
	<brief_summary>We propose conduct inpatient pilot study test safety potential efficacy topiramate naltrexone combination treatment alcoholism .</brief_summary>
	<brief_title>Combining Medications Treatment Alcohol Dependence : An Inpatient Preliminary Study</brief_title>
	<detailed_description>Eight ( n = 8 ) alcohol-dependent research volunteer , seek treatment , complete placebo-controlled , within-subject cross-over design alcohol-related control cue present stimuli induce alcohol-seeking behavior control laboratory condition repeat dose ( chronic ) treatment double-blind dos placebo topiramate + naltrexone.Subjects reside inpatient environment two separate 9-day block intersperse 1-week washout period . During separate block , topiramate + naltrexone placebo dos administer orally twice-daily regimen ( 08:00 h 20:00 h ) 8 days.Doses start even day 1 last dose give morning day 8 . No dos give even day 8 morning day 9 . On Days 7 8 dose regimen , subject receive alcohol alcohol-related cue correspond control cue .</detailed_description>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>DSMIVR diagnosis alcohol dependence . Currently drink . Good physical health determine complete physical examination , electrocardiogram within normal limit Negative pregnancy test intake . Women childbearing potential place oral contraceptive also expect use barrier spermicide additional form contraception sexually active . Literate English language , able read , understand , complete rating scale questionnaires accurately . Willingness comply study procedure protocol include agreement overnight stay human laboratory . Compliance alcohol , tobacco , drugfree environment regulation human laboratory also condition enrollment . Written informed consent . Expression desire immediate treatment alcohol drug addiction . History mental illness warrant treatment would preclude safe participation protocol except nicotine dependence , determine mental status psychiatric interview use Structured Clinical Interview DSMIV . Acute chronic organic brain syndrome , schizophrenia , bipolar disorder , psychotic disorder . Significant medical illness determine history and/or complete physical examination . Uncontrolled uterine cervical bleeding . History blood clot . Past problem oral contraceptive pill . Gross neurological disease . Mental retardation . Neurocognitive functioning &gt; 1.5 standard deviation expect range . If neurocognitive function test &gt; 1.5 standard deviation expect range Clinically significant abnormality electrocardiogram History ischemic heart disease myocardial infarction . History glaucoma uncontrolled symptomatic thyroid disease . Current infective hepatitis evidence clinical manifestation . If hepatitis suspect , hepatitis antibody/antigen screen do . Positive pregnancy test . Women 35 smoke exclude participate research study . Participation human laboratory clinical study within last 30 day . Clinically significant laboratory screen test ( LST ) result hematology , chemistry , urine analysis . History severe lifethreatening reaction topiramate naltrexone Past current history seizure disorder . Past current history kidney stone . Use carbonic anhydrase medication . Being treated medication potential interaction alcohol naltrexone . Pending imprisonment . For smoker , previous adverse reaction nicotine patch Reporting experience crave alcohol Postmenopausal woman recruit study . Chronic use NSAIDs</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Alcohol</keyword>
	<keyword>Alcoholism</keyword>
	<keyword>Alcohol Dependence</keyword>
</DOC>